Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1293269 Target Snapshot

NS3 · SINGLE PROTEIN · Hepatitis C virus

965Compounds
110Assays
6Approved Drugs
1,083.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt A3EZJ3. Use UniProt A3EZJ3 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt A3EZJ3 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats NS3 as ChEMBL target CHEMBL1293269, mapped to UniProt A3EZJ3. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
NS3
SINGLE PROTEIN · Hepatitis C virus
As of 2026-09-13
ChEMBL target ID
CHEMBL1293269
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
A3EZJ3
Genome polyprotein
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether NS3 is the right protein anchor across sources, using UniProt A3EZJ3 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGenome polyprotein
UniProt AccessionA3EZJ3
Component TypeProtein
Sequence Length631 aa

Genome polyprotein

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as NS3, mapped to UniProt A3EZJ3. ChEMBL maps the protein component as Genome polyprotein. Sequence length is 631 aa.

Mapped IDA3EZJ3
Review nameNS3
OrganismHepatitis C virus
Clinical Profile

Clinical Phase Distribution

6
Approved
3
Phase II
Assay Mix

Activity Type Distribution

IC50460.0
KI490.0
EC5043.0
KD90.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2063090 10.4 Ki 0.04 Approved
CHEMBL505440 10.3 Ki 0.05 Preclinical
CHEMBL3899923 10.1 Ki 0.08 Preclinical
CHEMBL297884 10.05 Ki 0.089 Clinical
CHEMBL3661086 10.0 Ki 0.1 Preclinical
CHEMBL489267 10.0 Ki 0.1 Preclinical
CHEMBL444708 10.0 Ki 0.1 Preclinical
CHEMBL4215698 9.7 EC50 0.2 Preclinical
CHEMBL3661088 9.6 Ki 0.25 Preclinical
CHEMBL4202696 9.52 EC50 0.3 Preclinical
Distribution

pChEMBL Value Distribution

150
5.0
89
5.5
111
6.0
106
6.5
102
7.0
74
7.5
42
8.0
19
8.5
16
9.0
12
9.5
pChEMBL
Approved Drugs

Approved Drugs

GRAZOPREVIR ANHYDROUS
CHEMBL2063090
Approved 2016
ASUNAPREVIR
CHEMBL2105735
Approved 2014
SIMEPREVIR
CHEMBL501849
Approved 2013
BOCEPREVIR
CHEMBL218394
Approved 2011
EPIRUBICIN
CHEMBL417
Approved 1999
TRIFLUOPERAZINE
CHEMBL422
Approved 1959
Assay Landscape

Assay Landscape

110
Total Assays
799
Tested Compounds
1
Assay Types
Binding — 110 assays, 799 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 105 777 6.3
cell-based format 5 22 8.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine